Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

Research Network

Collaboration Network

49 collaborators·60 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Institut Bergonié Bordeaux

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Eric FRANCOIS, Dr

Centre Antoine Lacassagne, Nice

Moderately Similar
4 trials

Shared therapeutic areas:

Colorectal CancerMalignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 2 trials
Similarity Score38%

Driffa MOUSSATA, Dr

Centre hospitalier Lyon Sud-PIERRE BENITE

Moderately Similar
2 trials

Shared therapeutic areas:

Colorectal CancerMalignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 2 trials
Similarity Score38%

Julien FORESTIER, Dr

Hôpital Edouard Herriot-LYON

Moderately Similar
2 trials

Shared therapeutic areas:

Colorectal CancerMalignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 2 trials
Similarity Score38%

Cédric LECAILLE, Dr

Polyclinique Bordeaux Nord Aquitaine-BORDEAUX

Moderately Similar
2 trials

Shared therapeutic areas:

Colorectal CancerMalignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score34%

Jaafar BENNOUNA, Dr

Centre René Gauducheau

Moderately Similar
2 trials

Shared therapeutic areas:

Colorectal CancerMalignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score34%

You Heng LAM, Dr

Centre Paul Papin-ANGERS

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Leila BENGRINE LEFEVRE, Dr

Hôpital Saint Antoine

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Hervé PERRIER, Dr

Hôpital Saint Joseph

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Emmanuel MAILLARD, Dr

CHR Annecy

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Eric TERREBONNE, Dr

Hôpîtal haut Lévèque

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01442935Phase 2PrincipalInvestigator

Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases

Colorectal Cancer
Completed
NCT01443065Phase 2PrincipalInvestigator

MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach
Completed

All 2 trials loaded